Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Predictors of Survival After Palliative Radiotherapy for Glioblastoma in a Real-World Cohort Study.

Current oncology (Toronto, Ont.)·2026
Same author

Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.

Current oncology (Toronto, Ont.)·2026
Same author

Neurofilament light and glial fibrillary acidic protein do not reflect neuronal or glial damage during different intracranial radiotherapy regimes: a pilot study.

Frontiers in oncology·2026
Same author

Deformable image registration accuracy: impact of user-defined parameter selection on contour propagation for deep inspiration breath-hold and free breathing breast radiotherapy.

BMC medical imaging·2026
Same author

Objective-function-guided automated VMAT planning reduces OAR dose, low-dose exposure, and inter-planner variability in breast radiotherapy.

Scientific reports·2026
Same author

Differential Cytokine and DNA Damage Response of Human Lung Tissue Models to Broad-Beam and Microbeam Radiotherapy.

Cells·2026

Related Experiment Video

Updated: Aug 18, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

Good Timing Matters: The Spatially Fractionated High Dose Rate Boost Should Come First.

Elisabeth Schültke1, Felix Jaekel1, Stefan Bartzsch2,3

  • 1Department of Radiooncology, Rostock University Medical Center, 18059 Rostock, Germany.

Cancers
|December 11, 2022
PubMed
Summary
This summary is machine-generated.

Integrating microbeam irradiation (MBI) or pencil beam irradiation (PBI) as a simultaneously integrated boost (SIB) early in radiotherapy schedules is crucial. Early integration of microbeam SIB minimizes risks of adverse effects like seizures and death in whole brain radiotherapy.

Keywords:
brain tissue tolerancehigh dose rate radiotherapymicrobeam irradiation (MBI)pencilbeam irradiation (PBI)

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Related Experiment Videos

Last Updated: Aug 18, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Preclinical Research

Background:

  • High dose rate radiotherapy utilizes spatial dose fractionation at the micrometre range.
  • Monoplanar microbeam irradiation (MBI) and pencil beam irradiation (PBI) are novel techniques.
  • Simultaneously integrated boost (SIB) delivery is explored in combination with conventional radiotherapy.

Purpose of the Study:

  • To investigate the integration of MBI or PBI as a SIB in a conventional whole brain radiotherapy (WBRT) schedule.
  • To evaluate the impact of SIB timing (early vs. late) on treatment outcomes.
  • To assess the safety and efficacy of microbeam SIB in a small animal model.

Main Methods:

  • MBI delivered as 50 µm wide microbeams; PBI delivered as 50 µm x 50 µm pencil beams, both with 400 µm center-to-center distance.
  • SIB integrated either at the beginning or end of 5x4 Gy broad beam (BB) WBRT.
  • Peak doses calculated to ensure minimum 4 Gy valley dose to the entire brain.

Main Results:

  • The sequence of BB fractions and microbeam SIB significantly impacts acute adverse effects.
  • Early integration of microbeam SIB reduced the risk of epileptic seizures and death.
  • Late integration of microbeam SIB was associated with increased adverse events.

Conclusions:

  • The timing of microbeam SIB delivery is critical for mitigating acute toxicity in WBRT.
  • Early incorporation of MBI or PBI as SIB is recommended for improved safety profiles.
  • This study provides valuable insights for optimizing advanced radiotherapy fractionation strategies.